News Headlines

Display #
Title
Takeda study brings dengue vaccine step closer
Mylan says EpiPen manufacturing partner to expand device recall
Astellas Takes Out Belgium Biotech in Deal Worth $853 Million
Troubled Sucampo Pays $200 Million Upfront for Rare Disease Biotech Vtesse
The cost of cancer: new drugs show success at a steep price
The first overall survival data from the Phase 3 CheckMate -067 clinical trial
Immunotherapy combo extends melanoma survival
Once-weekly semaglutide demonstrated consistent blood glucose reductions and weight loss regardless of background oral antidiabetic treatment
Sanofi to pay $19.8 million over claims of drug overcharges: U.S.
Mallinckrodt agrees to U.S. drug probe settlement
Espero Pharmaceuticals and Armetheon to Merge
Google Backs Another Biotech Startup
Former Pfizer Neuroscientist to Helm New York Biotech Vencerx
Novartis’ Talent Woes Continue as Seattle Genetics Poaches a Top CAR-T Exec
Changing the Learning Curve for Auto-Injection Therapy
High doses of vitamin C to improve cancer treatment passes human safety trial
Tagrisso Receives US FDA Full Approval
Jaguar Animal Health and Napo Pharmaceuticals Enter Definitive Merger Agreement
British robot helping autistic children with their social skills
The Rule of Three: Mapping Physician Engagement
GSK’s new CEO gets short-term win from generic Advair delay
Anti-cancer drug gets a boost when combined with antirheumatic
Daiichi Sankyo announces collaborative research on drugs for neglected tropical diseases
Novartis Wins Speedy Review of Leukemia Drug
Massachusetts’ Agenus to Phase Out 20% of Jobs, Shutter Switzerland Facility in Restructuring
Mass Layoffs Hit Ariad Employees After Takeda’s $5.2 Billion Buyout Deal
Corbus drug shows promise as add-on therapy for cystic fibrosis
Merck advances R&D strategy through unique development model with Avillion for Anti IL-17 A/F Nanobody
U.S.-UK alliance targets the world’s deadliest superbugs
Merrimack Stockholders Approve Sale of Onivyde and Generic Version of Doxil to Ipsen for Up to $1.025 Billion